vs

Side-by-side financial comparison of CABOT CORP (CBT) and Veralto (VLTO). Click either name above to swap in a different company.

Veralto is the larger business by last-quarter revenue ($1.4B vs $849.0M, roughly 1.7× CABOT CORP). Veralto runs the higher net margin — 17.9% vs 8.6%, a 9.3% gap on every dollar of revenue. On growth, Veralto posted the faster year-over-year revenue change (6.8% vs -11.1%). Veralto produced more free cash flow last quarter ($170.0M vs $57.0M). Over the past eight quarters, Veralto's revenue compounded faster (6.8% CAGR vs -8.7%).

Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices.

Veralto Corporation is an American technology company headquartered in Waltham, Massachusetts. It produces products related to water analytics, water treatment, marking and coding, and packaging and color.

CBT vs VLTO — Head-to-Head

Bigger by revenue
VLTO
VLTO
1.7× larger
VLTO
$1.4B
$849.0M
CBT
Growing faster (revenue YoY)
VLTO
VLTO
+17.9% gap
VLTO
6.8%
-11.1%
CBT
Higher net margin
VLTO
VLTO
9.3% more per $
VLTO
17.9%
8.6%
CBT
More free cash flow
VLTO
VLTO
$113.0M more FCF
VLTO
$170.0M
$57.0M
CBT
Faster 2-yr revenue CAGR
VLTO
VLTO
Annualised
VLTO
6.8%
-8.7%
CBT

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CBT
CBT
VLTO
VLTO
Revenue
$849.0M
$1.4B
Net Profit
$73.0M
$254.0M
Gross Margin
24.9%
60.1%
Operating Margin
15.2%
23.8%
Net Margin
8.6%
17.9%
Revenue YoY
-11.1%
6.8%
Net Profit YoY
-21.5%
12.9%
EPS (diluted)
$1.37
$1.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBT
CBT
VLTO
VLTO
Q1 26
$1.4B
Q4 25
$849.0M
$1.4B
Q3 25
$899.0M
$1.4B
Q2 25
$923.0M
$1.3B
Q1 25
$936.0M
Q4 24
$955.0M
$1.3B
Q3 24
$1.0B
$1.3B
Q2 24
$1.0B
$1.3B
Net Profit
CBT
CBT
VLTO
VLTO
Q1 26
$254.0M
Q4 25
$73.0M
$239.0M
Q3 25
$43.0M
$222.0M
Q2 25
$101.0M
$225.0M
Q1 25
$94.0M
Q4 24
$93.0M
$227.0M
Q3 24
$137.0M
$219.0M
Q2 24
$109.0M
$203.0M
Gross Margin
CBT
CBT
VLTO
VLTO
Q1 26
60.1%
Q4 25
24.9%
60.1%
Q3 25
24.5%
60.0%
Q2 25
26.4%
60.4%
Q1 25
25.7%
Q4 24
24.6%
59.6%
Q3 24
24.0%
59.6%
Q2 24
25.2%
60.1%
Operating Margin
CBT
CBT
VLTO
VLTO
Q1 26
23.8%
Q4 25
15.2%
23.2%
Q3 25
15.2%
22.8%
Q2 25
18.1%
24.2%
Q1 25
17.3%
Q4 24
16.2%
22.9%
Q3 24
15.0%
23.4%
Q2 24
16.9%
23.2%
Net Margin
CBT
CBT
VLTO
VLTO
Q1 26
17.9%
Q4 25
8.6%
17.0%
Q3 25
4.8%
16.2%
Q2 25
10.9%
16.9%
Q1 25
10.0%
Q4 24
9.7%
16.9%
Q3 24
13.7%
16.7%
Q2 24
10.7%
15.8%
EPS (diluted)
CBT
CBT
VLTO
VLTO
Q1 26
$1.02
Q4 25
$1.37
$0.95
Q3 25
$0.80
$0.89
Q2 25
$1.86
$0.90
Q1 25
$1.69
Q4 24
$1.67
$0.91
Q3 24
$2.41
$0.88
Q2 24
$1.94
$0.81

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBT
CBT
VLTO
VLTO
Cash + ST InvestmentsLiquidity on hand
$230.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.6B
Total Assets
$3.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBT
CBT
VLTO
VLTO
Q1 26
Q4 25
$230.0M
$1.8B
Q3 25
$258.0M
$1.6B
Q2 25
$239.0M
$1.2B
Q1 25
$213.0M
Q4 24
$183.0M
$1.1B
Q3 24
$223.0M
$1.3B
Q2 24
$197.0M
$1.0B
Total Debt
CBT
CBT
VLTO
VLTO
Q1 26
Q4 25
$2.7B
Q3 25
$1.1B
$2.7B
Q2 25
$2.6B
Q1 25
Q4 24
$2.6B
Q3 24
$1.1B
$2.6B
Q2 24
$2.6B
Stockholders' Equity
CBT
CBT
VLTO
VLTO
Q1 26
Q4 25
$1.6B
$2.8B
Q3 25
$1.6B
$2.7B
Q2 25
$1.5B
$2.3B
Q1 25
$1.4B
Q4 24
$1.4B
$2.0B
Q3 24
$1.4B
$2.0B
Q2 24
$1.3B
$1.7B
Total Assets
CBT
CBT
VLTO
VLTO
Q1 26
Q4 25
$3.8B
$7.4B
Q3 25
$3.8B
$7.2B
Q2 25
$3.8B
$6.6B
Q1 25
$3.8B
Q4 24
$3.6B
$6.4B
Q3 24
$3.7B
$6.3B
Q2 24
$3.6B
$5.9B
Debt / Equity
CBT
CBT
VLTO
VLTO
Q1 26
Q4 25
0.94×
Q3 25
0.70×
1.01×
Q2 25
1.14×
Q1 25
Q4 24
1.28×
Q3 24
0.75×
1.35×
Q2 24
1.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBT
CBT
VLTO
VLTO
Operating Cash FlowLast quarter
$126.0M
$182.0M
Free Cash FlowOCF − Capex
$57.0M
$170.0M
FCF MarginFCF / Revenue
6.7%
12.0%
Capex IntensityCapex / Revenue
8.1%
0.8%
Cash ConversionOCF / Net Profit
1.73×
0.72×
TTM Free Cash FlowTrailing 4 quarters
$401.0M
$893.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBT
CBT
VLTO
VLTO
Q1 26
$182.0M
Q4 25
$126.0M
$270.0M
Q3 25
$219.0M
$339.0M
Q2 25
$249.0M
$157.0M
Q1 25
$73.0M
Q4 24
$124.0M
$285.0M
Q3 24
$204.0M
$224.0M
Q2 24
$207.0M
$251.0M
Free Cash Flow
CBT
CBT
VLTO
VLTO
Q1 26
$170.0M
Q4 25
$57.0M
$258.0M
Q3 25
$155.0M
$323.0M
Q2 25
$188.0M
$142.0M
Q1 25
$1.0M
Q4 24
$47.0M
$263.0M
Q3 24
$112.0M
$215.0M
Q2 24
$155.0M
$240.0M
FCF Margin
CBT
CBT
VLTO
VLTO
Q1 26
12.0%
Q4 25
6.7%
18.4%
Q3 25
17.2%
23.6%
Q2 25
20.4%
10.7%
Q1 25
0.1%
Q4 24
4.9%
19.6%
Q3 24
11.2%
16.4%
Q2 24
15.3%
18.6%
Capex Intensity
CBT
CBT
VLTO
VLTO
Q1 26
0.8%
Q4 25
8.1%
0.9%
Q3 25
7.1%
1.2%
Q2 25
6.6%
1.1%
Q1 25
7.7%
Q4 24
8.1%
1.6%
Q3 24
9.2%
0.7%
Q2 24
5.1%
0.9%
Cash Conversion
CBT
CBT
VLTO
VLTO
Q1 26
0.72×
Q4 25
1.73×
1.13×
Q3 25
5.09×
1.53×
Q2 25
2.47×
0.70×
Q1 25
0.78×
Q4 24
1.33×
1.26×
Q3 24
1.49×
1.02×
Q2 24
1.90×
1.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBT
CBT

Reinforcement Materials$520.0M61%
Performance Chemicals$300.0M35%
Shipping And Handling$25.0M3%
Other Products And Services$4.0M0%

VLTO
VLTO

Segment breakdown not available.

Related Comparisons